Round out your CMHC educational experience by attending Professional Medical Education/Product Theater symposia focused on novel therapies. These non-certified activities are planned solely by the sponsoring organizations/companies. There are no additional fees to attend once you have registered for CMHC West and meals or refreshments may be provided. Register for CMHC West today and attend these activities.
Non-CME Lunch Symposium · Friday, May 3, 2019 · 12:15pm – 1:30pm · AKIMEL BALLROOM
Reduce Cardiovascular Risk With VASCEPA® (icosapent ethyl): Evidence From REDUCE-IT
Faculty: Krishnaswami Vijayaraghavan, MD
Despite the benefits of LDL-C lowering, many patients on statin therapy with elevated triglycerides remain at risk for cardiovascular disease. The unprecedented data from the VASCEPA® cardiovascular outcomes trial, REDUCE-IT™, and its potential impact on patient care will be evaluated in this presentation. In addition, the unique mechanisms of action and safety of single-agent, EPA-only VASCEPA will be reviewed. Join us at this program to discuss how to Reduce Cardiovascular Risk With VASCEPA® (icosapent ethyl): Evidence From REDUCE-IT™.
Visit the Amarin booth for more information.